BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 19210946)

  • 61. Clinical outcomes associated with comorbid posttraumatic stress disorder among patients with bipolar disorder.
    Passos IC; Jansen K; Cardoso Tde A; Colpo GD; Zeni CP; Quevedo J; Kauer-Sant'Anna M; Zunta-Soares G; Soares JC; Kapczinski F
    J Clin Psychiatry; 2016 May; 77(5):e555-60. PubMed ID: 27135375
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Mood stabilizers and atypical antipsychotics: bimodal treatments for bipolar disorder.
    Ketter TA; Nasrallah HA; Fagiolini A
    Psychopharmacol Bull; 2006; 39(1):120-46. PubMed ID: 17065977
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Comparison of 71 bipolar disorder pharmacotherapies for kidney disorder risk: The potential hazards of polypharmacy.
    Nestsiarovich A; Kerner B; Mazurie AJ; Cannon DC; Hurwitz NG; Zhu Y; Nelson SJ; Oprea TI; Unruh ML; Crisanti AS; Tohen M; Perkins DJ; Lambert CG
    J Affect Disord; 2019 Jun; 252():201-211. PubMed ID: 30986735
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Bouncing back: is the bipolar rebound phenomenon peculiar to lithium? A retrospective naturalistic study.
    Franks M; Macritchie KA; Mahmood T; Young AH
    J Psychopharmacol; 2008 Jun; 22(4):452-6. PubMed ID: 18635725
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The contemporary face of bipolar illness: complex diagnostic and therapeutic challenges.
    Fountoulakis KN
    CNS Spectr; 2008 Sep; 13(9):763-74, 777-9. PubMed ID: 18849896
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Long-term treatment of bipolar disorder: how should we use lithium salts?].
    Del Grande C; Muti M; Musetti L; Pergentini I; Corsi M; Turri M; Soldani I; Corsini GU; Dell'Osso L
    Riv Psichiatr; 2012; 47(6):515-26. PubMed ID: 23160112
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Bipolar depression: a review of current therapeutic strategies].
    Thuile J; Even C; Guelfi JD
    Encephale; 2006 Oct; 32(5 Pt 1):767-74. PubMed ID: 17099601
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Clinical and therapeutic implications of predominant polarity in bipolar disorder.
    Colom F; Vieta E; Daban C; Pacchiarotti I; Sánchez-Moreno J
    J Affect Disord; 2006 Jul; 93(1-3):13-7. PubMed ID: 16650901
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Comparison of early- and late-onset rapid cycling affective disorders: clinical course and response to pharmacotherapy.
    Fujiwara Y; Honda T; Tanaka Y; Aoki S; Kuroda S
    J Clin Psychopharmacol; 1998 Aug; 18(4):282-8. PubMed ID: 9690693
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Updates in treating comorbid bipolar disorder and obsessive-compulsive disorder: A systematic review.
    Amerio A; Maina G; Ghaemi SN
    J Affect Disord; 2019 Sep; 256():433-440. PubMed ID: 31234022
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Antipsychotic drugs, mood stabilizers, and risk of pneumonia in bipolar disorder: a nationwide case-control study.
    Yang SY; Liao YT; Liu HC; Chen WJ; Chen CC; Kuo CJ
    J Clin Psychiatry; 2013 Jan; 74(1):e79-86. PubMed ID: 23419234
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Selecting appropriate treatments for maintenance therapy for bipolar disorder.
    Thase ME
    J Clin Psychiatry; 2008; 69 Suppl 5():28-35. PubMed ID: 19265638
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Acute nonpsychotic mania: first episode.
    Allen MH
    CNS Spectr; 2009 Nov; 14(11 Suppl 11):3-6; discussion 12-4. PubMed ID: 20173693
    [No Abstract]   [Full Text] [Related]  

  • 74. Assessment of medication adherence in a cohort of patients with bipolar disorder.
    González-Pinto A; Reed C; Novick D; Bertsch J; Haro JM
    Pharmacopsychiatry; 2010 Nov; 43(7):263-70. PubMed ID: 20842617
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Association between antipsychotic combination therapy and treatment adherence among individuals with bipolar disorder.
    Gianfrancesco FD; Sajatovic M; Tafesse E; Wang RH
    Ann Clin Psychiatry; 2009; 21(1):3-16. PubMed ID: 19239828
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Asenapine as adjunctive treatment for acute mania associated with bipolar disorder: results of a 12-week core study and 40-week extension.
    Szegedi A; Calabrese JR; Stet L; Mackle M; Zhao J; Panagides J;
    J Clin Psychopharmacol; 2012 Feb; 32(1):46-55. PubMed ID: 22198448
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Antidepressant-induced mania in bipolar patients: identification of risk factors.
    Henry C; Sorbara F; Lacoste J; Gindre C; Leboyer M
    J Clin Psychiatry; 2001 Apr; 62(4):249-55. PubMed ID: 11379838
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Lithium Treatment in the Prevention of Repeat Suicide-Related Outcomes in Veterans With Major Depression or Bipolar Disorder: A Randomized Clinical Trial.
    Katz IR; Rogers MP; Lew R; Thwin SS; Doros G; Ahearn E; Ostacher MJ; DeLisi LE; Smith EG; Ringer RJ; Ferguson R; Hoffman B; Kaufman JS; Paik JM; Conrad CH; Holmberg EF; Boney TY; Huang GD; Liang MH;
    JAMA Psychiatry; 2022 Jan; 79(1):24-32. PubMed ID: 34787653
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The pattern of pharmacological treatment of bipolar patients discharged from psychiatric units in Poland.
    Jaracz J; Rudnicka ET; Bierejszyk M; Witczyk K; Raczyńska A; Nowak W; Pisarczyk A; Woźniak K; Czernaś W; Moniakowski A; Jaracz K
    Pharmacol Rep; 2018 Aug; 70(4):694-698. PubMed ID: 29933206
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Adjunctive oral ziprasidone in patients with acute mania treated with lithium or divalproex, part 1: results of a randomized, double-blind, placebo-controlled trial.
    Sachs GS; Vanderburg DG; Karayal ON; Kolluri S; Bachinsky M; Cavus I
    J Clin Psychiatry; 2012 Nov; 73(11):1412-9. PubMed ID: 23218157
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.